ArticleScientific reports2025
A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system.
Dan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it